Literature DB >> 12659674

Hybrid yeast-bacteria cloning system used to capture and modify adenoviral and nonviral genomes.

Craig A Hokanson1, Emery Dora, Brian A Donahue, Marianne Rivkin, Mitchell Finer, Michael J Mendez.   

Abstract

Adenoviral vectors are widely used to express transgenes in vitro and in vivo. A major obstacle to the generation of adenoviral vectors is the manipulation of the large (35 kb) adenoviral genome. We developed a hybrid yeast-bacteria cloning system for the creation of novel adenoviral vectors. The adenovirus 5 (Ad5) genome was cloned into a shuttle vector that contains both yeast and bacterial elements for replication and therefore functions as both a yeast artificial plasmid (YAP) and as a plasmid artificial chromosome (PAC). Any sequence can be introduced into any region of the adenoviral genome via the highly efficient homologous recombination in yeast and then these recombinants are rapidly amplified in bacteria. Adenoviral vectors are generated by introduction of the PAC into the appropriate complementing mammalian cell without the need for plaque purification. Vectors were constructed with deletions in the E1, E3, and/or E4 regions. We have generated more than 100 vectors with a number of different transgenes and regulatory elements. In addition, the YAP/PAC vector was used to capture a DNA fragment encompassing the human factor IX gene, demonstrating the utility of this system to clone and analyze genomic DNA. This novel cloning strategy allows the rapid and versatile construction of adenoviral vectors for gene expression and gene therapy applications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12659674     DOI: 10.1089/104303403321208934

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  4 in total

Review 1.  Latest Advances of Virology Research Using CRISPR/Cas9-Based Gene-Editing Technology and Its Application to Vaccine Development.

Authors:  Man Teng; Yongxiu Yao; Venugopal Nair; Jun Luo
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

2.  An exogenous chloroplast genome for complex sequence manipulation in algae.

Authors:  Bryan M O'Neill; Kari L Mikkelson; Noel M Gutierrez; Jennifer L Cunningham; Kari L Wolff; Shawn J Szyjka; Christopher B Yohn; Kevin E Redding; Michael J Mendez
Journal:  Nucleic Acids Res       Date:  2011-11-23       Impact factor: 16.971

Review 3.  CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses.

Authors:  Ming Yuan; Eika Webb; Nicholas Robert Lemoine; Yaohe Wang
Journal:  Viruses       Date:  2016-03-07       Impact factor: 5.048

Review 4.  The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems.

Authors:  Luyao Wang; Yurong Chen; Xinrui Liu; Ziyi Li; Xiangpeng Dai
Journal:  Front Oncol       Date:  2022-01-17       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.